BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 2891276)

  • 41. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.
    Wang W; Butler EN; Veguilla V; Vassell R; Thomas JT; Moos M; Ye Z; Hancock K; Weiss CD
    J Virol Methods; 2008 Nov; 153(2):111-9. PubMed ID: 18722473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The antibody activity to synthetic C-terminal fragments of the heavy-chain hemagglutinins of influenza virus A subtypes H1 and H3].
    Mazurkova NA; Kalashnikov VV; Mizenko GA; Samukov VV; Podcherniaeva RIa
    Vopr Virusol; 1990; 35(4):283-6. PubMed ID: 2256311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants.
    Graves PN; Schulman JL; Young JF; Palese P
    Virology; 1983 Apr; 126(1):106-16. PubMed ID: 6189287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.
    Vanlandschoot P; Beirnaert E; Barrère B; Calder L; Millar B; Wharton S; Jou WM; Fiers W
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1781-91. PubMed ID: 9680143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.
    Lim AP; Chan CE; Wong SK; Chan AH; Ooi EE; Hanson BJ
    Virol J; 2008 Oct; 5():130. PubMed ID: 18957074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A common antigenic epitope in influenza A virus (H1, H2, H5, H6) hemagglutinin].
    Smirnov IuA; Lipatov AS; Okuno I; Gitel'man AK
    Vopr Virusol; 1999; 44(3):111-5. PubMed ID: 10392433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody.
    Vanlandschoot P; Beirnaert E; Dewilde S; Saelens X; Bestebroer T; De Jong J; Jou WM; Fiers W
    Virology; 1995 Oct; 212(2):526-34. PubMed ID: 7571422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.
    Nakajima S; Nobusawa E; Nakajima K
    Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Preparation of monoclonal antibodies against HA protein of subtype H1 of swine influenza virus].
    Li HT; Liu M; Liu CG; Du JL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):233-5. PubMed ID: 19257989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
    Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristic features of InfA-15 monoclonal antibody recognizing H1, H3, and H5 subtypes of hemagglutinin of influenza virus A type.
    Hifumi E; Fujimoto N; Ishida K; Kawawaki H; Uda T
    J Biosci Bioeng; 2010 Jun; 109(6):598-608. PubMed ID: 20471600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin.
    Tamura M; Webster RG; Ennis FA
    J Immunol; 1993 Aug; 151(3):1731-8. PubMed ID: 7687637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of immunization with syngeneic monoclonal anti-idiotype antibody on antibody responses to influenza viruses.
    Schulman JL; Moran TM; Reale M; Beilin Y; Sigal N; Bona CA
    Monogr Allergy; 1987; 22():143-9. PubMed ID: 3501830
    [No Abstract]   [Full Text] [Related]  

  • 54. Characterization of subtype-specific and cross-reactive helper-T-cell clones recognizing influenza virus hemagglutinin.
    Brown LE; Katz JM; Ffrench RA; Anders EM; White DO
    Cell Immunol; 1987 Oct; 109(1):12-24. PubMed ID: 2958139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of influenza-immune T cell effector function by virus-specific hybridoma antibody.
    Effros RB; Frankel ME; Gerhard W; Doherty PC
    J Immunol; 1979 Sep; 123(3):1343-6. PubMed ID: 313952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies.
    Pifat DY; Osterling MC; Smith JF
    Virology; 1988 Dec; 167(2):442-50. PubMed ID: 2462308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic and genetic conservation of the haemagglutinin in H1N1 swine influenza viruses.
    Noble S; McGregor MS; Wentworth DE; Hinshaw VS
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1197-200. PubMed ID: 8389804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies.
    Gitelman AK; Kaverin NV; Kharitonenkov IG; Rudneva IA; Sklyanskaya EL; Zhdanov VM
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2247-51. PubMed ID: 3760825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A simple and rapid characterization of influenza virus isolates by monoclonal antibodies in radioimmunoassay.
    Kostolanský F; Styk B; Russ G
    Acta Virol; 1986 May; 30(3):267-70. PubMed ID: 2874733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.